Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191242 · ClinicalTrials.gov registry record
Methadone Monitoring for Insights Into Adverse Events
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 31
- Enrollment target
NCT01191242 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 31 participants.
The verdict
NCT01191242 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been suggested, increased drug concentration in the blood, and a change in the heart rhythm. This study will look at blood samples for drug levels and genetic components and EKG's (a noninvasive test which reveals heart rhythm). There will be no intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01191242
The ClinicalTrials.gov registry entry for NCT01191242 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01191242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01191242 about?
NCT01191242 is a clinical study titled "Methadone Monitoring for Insights Into Adverse Events". Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been suggested, increased drug concentration in the blood, and a change in the heart rhythm. This study ...
What is the current status of trial NCT01191242?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2010-08. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT01191242?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.